These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18287889)

  • 41. The effects of nebivolol on fibrinolytic parameters in mild and moderate hypertensive patients.
    Tarighi B; Kurum T; Demir M; Azcan SN
    Can J Cardiol; 2007 Jun; 23(8):651-5. PubMed ID: 17593991
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of nebivolol and atenolol on insulin sensitivity and haemodynamics in hypertensive patients.
    Poirier L; Cléroux J; Nadeau A; Lacourcière Y
    J Hypertens; 2001 Aug; 19(8):1429-35. PubMed ID: 11518851
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Influence of nebivolol on left ventricular remodeling in patients with arterial hypertension without chronic heart failure].
    Khurs EM; Zinov'eva IuA; Poddubnaia AV; Smolenskaia OG
    Kardiologiia; 2007; 47(12):15-9. PubMed ID: 18260973
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Nebivolol, a beta blocker of the 3rd generation: modern therapy of arterial hypertension. Results of a multicenter observation study].
    von Fallois J; Faulhaber HD
    Praxis (Bern 1994); 2001 Mar; 90(11):435-41. PubMed ID: 11293936
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of nebivolol and atenolol on small arteries and microcirculatory endothelium-dependent dilation in hypertensive patients undergoing isometric stress.
    Arosio E; De Marchi S; Prior M; Zannoni M; Lechi A
    J Hypertens; 2002 Sep; 20(9):1793-7. PubMed ID: 12195121
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nationwide efficacy-safety study of nebivolol in mildly hypertensive patients.
    Cleophas TJ; Agrawal R; Lichtenthal A; Mäkel W; Fici F
    Am J Ther; 2006; 13(3):192-7. PubMed ID: 16772759
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Nebivolol effects on the cardiovascular system and the kidneys in pregnant and puerperal women with hypertension].
    Tkacheva ON; Vertkin AL; Barabashkina AV; Vasil'eva AV; Razguliaeva NF
    Ter Arkh; 2006; 78(10):56-61. PubMed ID: 17180940
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nebivolol: an endothelium-friendly selective β1-adrenoceptor blocker.
    Gao Y; Vanhoutte PM
    J Cardiovasc Pharmacol; 2012 Jan; 59(1):16-21. PubMed ID: 21283024
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential effects of nebivolol and metoprolol on central aortic pressure and left ventricular wall thickness.
    Kampus P; Serg M; Kals J; Zagura M; Muda P; Karu K; Zilmer M; Eha J
    Hypertension; 2011 Jun; 57(6):1122-8. PubMed ID: 21536983
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacological mechanisms of clinically favorable properties of a selective beta1-adrenoceptor antagonist, nebivolol.
    Kuroedov A; Cosentino F; Lüscher TF
    Cardiovasc Drug Rev; 2004; 22(3):155-68. PubMed ID: 15492765
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effect of enape combined with nebilet in hypertension].
    Gol'drin EN; Samokhina LM
    Lik Sprava; 2002; (7):104-7. PubMed ID: 12587324
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial.
    Weiss RJ; Stapff M; Lin Y
    Am J Cardiovasc Drugs; 2013 Apr; 13(2):129-40. PubMed ID: 23519546
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Verapamil and nebivolol improve carotid artery distensibility in hypertensive patients.
    van Merode T; van Bortel LM; Smeets FA; Mooij JM; Bohm RO; Rahn KH; Reneman RS
    J Hypertens Suppl; 1989 Dec; 7(6):S262-3. PubMed ID: 2576665
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effects of nebivolol on microcirculation, platelet aggregation and blood viscosity in patients with essential hypertension].
    Zadionchenko VS; Sandomirskaia AP; Adasheva TV; Gorbacheva EV; Matveev DV; Mareeva AP; Buval'tsev VI
    Kardiologiia; 2002; 42(5):14-8. PubMed ID: 12494141
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nitric oxide mechanisms of nebivolol.
    Maffei A; Lembo G
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):317-27. PubMed ID: 19443516
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinico-immunological disorders in patients with ischemic heart disease combined with metabolic syndrome and modulating effect of nebivolol for their correction].
    Tepliakov AT; Bolotskaia LA; Vdovina TV; Stepacheva TA; Kuznetsova AV
    Ter Arkh; 2008; 80(12):44-52. PubMed ID: 19227907
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A review of the safety and efficacy of nebivolol in the mildly hypertensive patient.
    Cockcroft J
    Vasc Health Risk Manag; 2007; 3(6):909-17. PubMed ID: 18200810
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nebivolol therapy improves endothelial function and increases exercise tolerance in patients with cardiac syndrome X.
    Sen N; Tavil Y; Erdamar H; Yazici HU; Cakir E; Akgül EO; Bilgi C; Erbil MK; Poyraz F; Okyay K; Turfan M; Cemri M
    Anadolu Kardiyol Derg; 2009 Oct; 9(5):371-9. PubMed ID: 19819787
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The use of beta blocker Nebivolol in patients with chronic obstructive pulmonary disease in association with arterial hypertension.
    Martiniuc C; Branishte T
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(1):218-21. PubMed ID: 23077899
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of nebivolol and enalapril on metabolic parameters and arterial stiffness in hypertensive type 2 diabetic patients.
    Kaiser T; Heise T; Nosek L; Eckers U; Sawicki PT
    J Hypertens; 2006 Jul; 24(7):1397-403. PubMed ID: 16794490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.